GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 68.58 | 54.33 | -44.26 | 17.00 | 52.46 |
What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 68.58 |
| Mar2025 | 54.33 |
| Mar2024 | -44.26 |
| Mar2023 | 17.00 |
| Mar2022 | 52.46 |
How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 68.58 | 26.23 | |
| Mar2025 | 54.33 | Positive | |
| Mar2024 | -44.26 | Negative | |
| Mar2023 | 17 | -67.59 | |
| Mar2022 | 52.46 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹68,856.8 Cr | 5% | 11.7% | 24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5% |
11.7% |
24.6% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses